Xu et al. demonstrated that A-FABP levels were not only associated with insulin resistance, adiposity, dyslipidemia and glucose tolerance parameters, but also predicted the development of the metabolic syndrome and type 2 diabetes in 5-year and 10-year prospective studies [11], [21], [22]. This evidence concerns the gene FABP4 and type 2 diabetes mellitus.